Cancer Blood Tests At Home

Are you looking for tumour marker tests to learn if you have cancer? These tests can also help doctors to learn more about your cancer and help to plan treatment.
Check Available Slots

What is a CEA test?

A carcinoembryonic antigen (CEA) test is used to help diagnose certain cancers. CEA is an antigen released by cancerous tumour cells. The test is recommended if you have a family history of colon cancer or if you have symptoms of certain cancers such as: colon cancer, breast cancer, medullary thyroid carcinoma, cancer of the gastrointestinal tract, liver cancer, lung cancer, ovarian cancer, pancreatic cancer or prostate cancer. It can also be used to monitor the treatment of existing cancer. 

Learn More
B

Carcino Embryonic Antigen CEA

CEA

Carcinoembryonic antigen (CEA) is a protein that is present in certain tissues of a developing baby (foetus). By the time a baby is born, it drops to a very low level. In adults, CEA is normally present at very low levels in the blood but may be elevated with certain types of cancer. This test measures the amount of CEA in the blood to help evaluate individuals diagnosed with cancer.


CEA is a tumour marker. Originally, it was thought that CEA was a specific marker for colon cancer, but further study has shown that an increase in CEA may be seen in a wide variety of other cancers. CEA can also be increased in some non-cancer-related conditions, such as inflammation, cirrhosis, peptic ulcer, ulcerative colitis, rectal polyps, emphysema, and benign breast disease, and in smokers. For this reason, it is not useful as a general cancer screening tool, but it does have a role in evaluating response to cancer treatment. When an individual has been diagnosed with cancer, an initial baseline test for CEA may be performed. If this level is elevated, then subsequent serial testing of CEA may be performed to monitor the cancer as the individual undergoes treatment.

1 working day

£74.00

Excludes visit fee

View Details

Breast Cancer Test

The cancer antigen 15-3 is used to monitor response to breast cancer treatment and disease recurrence. If you are diagnosed with breast cancer that has spread to other parts of the body (metastasized) you will likely be referred for this test. It is not often measured at the early stages of breast cancer as it is rarely higher than normal at this stage. In general the higher the CA15-3 the more cancer there is in the body. If the level of CA15-3 starts to fall it indicates the treatment is working.
Learn More
B

CA 15-3 (Breast tumour marker)

C153

Cancer antigen 15-3 (CA 15-3) is a protein that is produced by normal breast cells. In many people with cancerous breast tumours, there is an increased production of CA 15-3 and the related cancer antigen 27.29. CA 15-3 does not cause cancer; rather, it is shed by the tumour cells and enters the blood. This test measures CA 15-3 in the blood.


Since CA 15-3 can be measured in the blood, it is useful as a tumour marker to follow the course of cancer. CA 15-3 is elevated in fewer than 50% of women with early localized, breast cancer or with a small tumour, but is elevated in about 80% of those with breast cancer that has spread (metastatic). Because not all women with invasive breast cancer will have elevated CA 15-3, the test is not useful in all cases.


CA 15-3 is not recommended as a screening test to detect breast cancer in women because it is non-specific. It may also be elevated in healthy people and in individuals with other cancers such as colon, lung, pancreas, ovarian, or prostate malignancies or certain conditions such as cirrhosis, hepatitis, and benign breast disease.

1 working day

£118.00

Excludes visit fee

View Details

Pancreatic Cancer Test

CA19-9 blood test is used to monitor the progress of pre-existing cancer or to assess the effectiveness of cancer treatment. Levels of the tumour marker go up as cancer spread or down it the tumour shrinks. Most commonly it is used for pancreatic cancer but it can be used for bile duct cancer, colon cancer and stomach cancer. The test is not normally used to diagnose pancreatic cancer as levels are often low in people with very early stages of the disease and high levels can indicate conditions other than cancer such as cirrhosis, cystic fibrosis, gallstones,
Learn More
B

CA 19-9 (Pancreatic tumour marker)

C199

Cancer antigen 19-9 (CA 19-9) is a protein that exists on the surface of certain cancer cells. CA 19-9 does not cause cancer; rather, it is shed by the tumour cells and can be detected by laboratory tests in blood and sometimes other body fluids. This test measures the level of CA19-9.


Since CA 19-9 can be measured in blood, it is useful as a tumour marker to follow the course of cancer. CA 19-9 is elevated in about 70% to 95% of people with advanced pancreatic cancer. However, CA 19-9 may also be elevated in other cancers, conditions, and diseases such as: gallbladder and bile duct cancers (cholangiocarcinoma), colorectal cancer, gastric cancers, ovarian cancer, lung cancer, liver cancer, bile duct obstruction (e.g., gallstones), pancreatitis, cystic fibrosis, thyroid disease, and liver disease. Small amounts of CA 19-9 are present in the blood of healthy people. Since CA 19-9 is not specific for pancreatic cancer, it cannot be used by itself for screening or diagnosis.

1 working day

£117.00

Excludes visit fee

View Details

Gastrointestinal Cancer Test

CA 50  is a broad tumour marker. A tumour market is released by cancerous cells into the blood steam. As a result detecting CA-50 in the blood can indicate you are suffering from a form of cancer such as gastrointestinal tract cancer or pancreatic It is most useful to determine the effectiveness of the treatment or progression of existing cancer rather than for screening for cancer as a high level can indicate other conditions such as pancreatitis, colitis and pneumonia. If your level of CA 50 increases it indicates the cancer has spread, if it falls the tumour has shrunk.
B

CA-50 (gastrointestinal tumour marker)

CA50

A CA-50 blood test identifies cancer markers in the blood to help monitor certain cancers such as gastrointestinal tract cancer and pancreatic cancer.

5 working days

£146.00

Excludes visit fee

View Details

Gastrointestinal/Ovarian Cancer Test

A CA 72-4 is a tumour marker that is released by cancerous cells into the bloodstream. It is released by cancers such as pancreatic, stomach, colon, cervix, gastrointestinal tract and ovarian. However, you may also have elevated CA 72-4 for other conditions such as rheumatic diseases or ovarian cysts. It is mainly used to monitor the effectiveness of treatment of gastrointestinal cancer and ovarian cancer. If the level of CA 72-4 in your blood increases it indicates the cancer has spread, if the level of CA 74-4 falls it indicates the tumour has shrunk. It is often accompanied with a CA 19-9 blood test as a second marker.
Learn More
B

Cancer Antigen 72-4 (CA 72-4)

C724

A CA 72-4 test identifies cancer markers in the blood. The test can be used to monitor a range of cancers including the gastrointestinal tract and ovarian.

5 working days

£126.00

Excludes visit fee

View Details

Polycystic Ovary Test

Do you want to test for polycystic ovary syndrome profile with a simple blood test? Polycystic Ovary syndrome is one of the top causes of women struggling to get pregnant. It is a hormone imbalance that causes fertility issues, weight gain and irregular periods.
Learn More
B

Polycystic Ovary Syndrome short profile

PCOS

Polycystic ovarian syndrome (PCOS) is a common condition, affecting up to a quarter of women of childbearing age. The disorder is one of the most common hormonal abnormalities in women of reproductive age and is a leading cause of infertility. Although the underlying cause is not well understood, PCOS is generally characterised by an excess production of androgens (male hormones - usual testosterone), lack of ovulation i.e. anovulation (the egg is not released by the ovary) and absence of menstrual periods (amenorrhoea), and by a varying degree of insulin resistance. The ovaries usually have many fluid-filled sacs (cysts) hence the name of the condition.


This profile measures the amount of the minimum number of hormones in the blood related with PCOS including Free Androgen Index – is a ratio used to determine abnormal androgen status in humans.

1 working day

£172.00

Excludes visit fee

View Details

How does VisitHealth work?

  • undefined

    Step 1: Book a home visit

    Book an appointment via our website or email/call our team. A visit fee will apply depending on your location and appointment time.
    Check Available Appointments
  • undefined

    Step 2: Meet our practitioner

    We come to you on the day your visit is booked. VH practitioner will have all the required equipment to provide medical care to you and your family.
    Meet Our Nurses
  • undefined

    Step 3: Get the results

    We deliver results electronically via email or by post to you or your doctor. Our practitioners can liaise with your doctor to help you get the care or tests you need.
    Check FAQ

Do you have any questions and want our team to get in touch with you?

    Should You Get a Cancer Blood Test at Home?

    Cancer has long been one of the biggest threats to our health in Britain, accounting for more than a quarter of all deaths in the UK. Usually, someone in the UK is diagnosed with cancer every 2 minutes and the survival rate is just 50%.
    Read More